Caroverine and Inner Ear Diseases

The study will investigate the transtympanic treatment with a 1,5% caroverine solution.

  1. Tinnitus Talk
    This trial is a randomized, double blind, placebo controlled study on patients suffering from inner ear diseases with tinnitus as a principal symptom.

    The study will investigate the transtympanic treatment with a 1,5 % caroverine solution.

    Each patient will undergo treatment for 2 cycles of 48 hours each.

    Estimated Enrollment: 170
    Study Start Date: January 2011
    Estimated Primary Completion Date: January 2012 (Final data collection date for primary outcome measure)
If you have ringing ears then you've come to the right place. We are a friendly tinnitus support board, dedicated to helping you discuss and understand what tinnitus treatments may work for you.